India · Delayed Price · Currency is INR Lyka Labs Company Description
Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients in India.
The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant tablets and combination, proton pump inhibitor, nutraceuticals, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, anti-fungal and bacterial, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products.
It also offers technical data, such as molecule stability testing data, impurity profile, and BA/BE clinical study data.
The company offers its products in various forms, including injections, creams, ointments, foams, gels, and lotions.
It also exports its products. The company was incorporated in 1976 and is based in Mumbai, India.
| Country | India |
| Founded | 1976 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 499 |
| CEO | Kunal Gandhi |
Contact Details
Address: Spencer Building Mumbai, Gujarat 400036 India | |
| Phone | 91 22 6611 2200 |
| Website | lykalabs.com |
Stock Details
| Ticker Symbol | LYKALABS |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE933A01014 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Kunal Narendra Gandhi | MD, Chief Executive Officer, Promoter and Director |
| Yogesh Babulal Shah | Chief Financial Officer and Executive Director |